KNACK PHARMA
Dead / Abandoned — Abandoned — incomplete response (as of 02 Jun 2022)
What this means for you
This application is over — abandoned 18 Mar 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87817016
- Mark type
- Stylized text
- Filed
- 01 Mar 2018
- Published for opposition
- 17 Jul 2018
- Abandoned
- 18 Mar 2022
- Attorney of record
- Tomas Maria Casalins
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of epilepsy disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of skin diseases, allergies and rheumatic disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of Alzheimer; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of ophthalmic related disorders and diseases; Pharmaceutical preparations for the treatment and prevention of musculoskeletal related diseases and disorders; Pharmaceutical preparations for the support and promotion of bone strength and health; Pharmaceutical preparations for the treatment of bone disorders and bone diseases; Pharmaceutical preparations for the treatment of toxic effects; Pharmaceutical preparations for use as injectable anesthetics; Pharmaceutical preparations for use as contraceptives; Pharmaceutical preparations for fertility enhancement purposes; Pharmaceutical preparations for use in hormone replacement therapy; Pharmaceutical preparations for the prevention and treatment of hormone disorders and deficiencies; Pharmaceutical preparations for inducing labor and facilitating nursing; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the treatment and prevention of metabolic, endocrine and kidney related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of nausea and vomiting; Pharmaceutical preparations for the prevention and treatment of aids-related disorders and diseases; Pharmaceutical preparations for treatment and prevention of viral and bacterial infections; Pharmaceutical preparations, namely, injectable contraceptives
Owner
- KNACK PHARMACEUTICALS, INC., New York City, NY, US
- KNACK PHARMACEUTICALS, INC., New York City, NY, US
Prosecution history
- 02 Jun 2022 — ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE
- 02 Jun 2022 — ABANDONMENT - INCOMPLETE RESPONSE
- 28 Apr 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Apr 2022 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 28 Apr 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 28 Apr 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Apr 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Apr 2022 — NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
- 14 Apr 2022 — NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
- 14 Apr 2022 — SU - NOTICE OF UNRESPONSIVE AMENDMENT - WRITTEN
- 21 Mar 2022 — ASSIGNED TO EXAMINER
- 18 Mar 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Mar 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Mar 2022 — ASSIGNED TO LIE
- 16 Mar 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED